UK Uterine Fibroid Treatment Device Market Size & Outlook, 2027

Revenue, 2020 (US$M)

$172.2

Forecast, 2027 (US$M)

$343.6

CAGR, 2021 - 2027

10.4%

Report Coverage

UK uterine fibroid treatment device market, 2016-2027 (US$M)

Related Markets

Global Uterine Fibroid Treatment Device Industry

North America Uterine Fibroid Treatment Device Market Outlook

U.S. Uterine Fibroid Treatment Device Market Outlook

Canada Uterine Fibroid Treatment Device Market Outlook

Europe Uterine Fibroid Treatment Device Market Outlook

Germany Uterine Fibroid Treatment Device Market Outlook

France Uterine Fibroid Treatment Device Market Outlook

Italy Uterine Fibroid Treatment Device Market Outlook

Spain Uterine Fibroid Treatment Device Market Outlook

Asia Pacific Uterine Fibroid Treatment Device Market Outlook

Japan Uterine Fibroid Treatment Device Market Outlook

China Uterine Fibroid Treatment Device Market Outlook

India Uterine Fibroid Treatment Device Market Outlook

Australia Uterine Fibroid Treatment Device Market Outlook

South Korea Uterine Fibroid Treatment Device Market Outlook

Latin America Uterine Fibroid Treatment Device Market Outlook

Mexico Uterine Fibroid Treatment Device Market Outlook

Argentina Uterine Fibroid Treatment Device Market Outlook

Colombia Uterine Fibroid Treatment Device Market Outlook

Brazil Uterine Fibroid Treatment Device Market Outlook

MEA Uterine Fibroid Treatment Device Market Outlook

South Africa Uterine Fibroid Treatment Device Market Outlook

Saudi Arabia Uterine Fibroid Treatment Device Market Outlook

UAE Uterine Fibroid Treatment Device Market Outlook

UK uterine fibroid treatment device market highlights

The UK uterine fibroid treatment device market generated a revenue of USD 172.2 million in 2020 and is expected to reach USD 343.6 million by 2027.
The UK market is expected to grow at a CAGR of 10.4% from 2021 to 2027.
In terms of segment, surgical technologies was the largest revenue generating technology in 2020.
Ablation Techniques is the most lucrative technology segment registering the fastest growth during the forecast period.

Uterine fibroid treatment device market data book summary

Market revenue in 2020	USD 172.2 million
Market revenue in 2027	USD 343.6 million
Growth rate	10.4% (CAGR from 2020 to 2027)
Largest segment	Surgical technologies
Fastest growing segment	Ablation Techniques
Historical data	2016 - 2019
Base year	2020
Forecast period	2021 - 2027
Quantitative units	Revenue in USD million
Market segmentation	Surgical Technologies, Ablation Techniques, Laparoscopic Techniques, Embolization Techniques
Key market players worldwide	Medtronic PLC, Boston Scientific Corp, Stryker Corp, CooperSurgical, Hologic Inc, Lumenis, InSightec

Other key industry trends

In terms of revenue, UK accounted for 3.5% of the global uterine fibroid treatment device market in 2020.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2027.
In Europe, Germany uterine fibroid treatment device market is projected to lead the regional market in terms of revenue in 2027.
UK is the fastest growing regional market in Europe and is projected to reach USD 343.6 million by 2027.

Key Regions: U.S. , Japan , Brazil , UAE , Canada

No credit card required*

Horizon in a snapshot

30K+ Global Market Reports
120K+ Country Reports
1.2M+ Market Statistics
200K+ Company Profiles
Industry insights and more

Uterine Fibroid Treatment Device Market Scope

Uterine fibroid treatment device market segmentation & scope

Uterine Fibroid Treatment Device Market Companies

Name	Profile	# Employees	HQ	Website

UK uterine fibroid treatment device market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to uterine fibroid treatment device market will help companies and investors design strategic landscapes.

Surgical technologies was the largest segment with a revenue share of 32.23% in 2020. Horizon Databook has segmented the UK uterine fibroid treatment device market based on surgical technologies, ablation techniques, laparoscopic techniques, embolization techniques covering the revenue growth of each sub-segment from 2016 to 2027.

UK Uterine Fibroid Treatment Device Technology Outlook (Revenue, USD Million, 2016-2027)
- Surgical Technologies
  - Hysterectomy
  - Myomectomy
- Ablation Techniques
  - Microwave Ablation
  - Hydrothermal Ablation
  - Cryoablation
  - Ultrasound Ablation
    - High Intensity Focused Ultrasound (HIFU)
    - MRI-guided Focused Ultrasound (MRgFUS)
- Laparoscopic Techniques
  - Laparoscopic Myotectomy
  - Myolysis
- Embolization Techniques
UK Uterine Fibroid Treatment Device Mode of Treatment Outlook (Revenue, USD Million, 2016-2027)
- Invasive Treatment
- Minimally Invasive Treatment
- Non-invasive Treatment

Reasons to subscribe to UK uterine fibroid treatment device market databook:

Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of UK uterine fibroid treatment device market databook

Our clientele includes a mix of uterine fibroid treatment device market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the UK uterine fibroid treatment device market, including forecasts for subscribers. This country databook contains high-level insights into UK uterine fibroid treatment device market from 2016 to 2027, including revenue numbers, major trends, and company profiles.